patent_istock-643607264_warchi-
warchi / iStockphoto.com
12 April 2018Asia

Chugai abandons patent claim against Nippon Kayaku

Japan-based Chugai Pharmaceuticals has announced it has withdrawn its patent infringement claim against generic anti-cancer business Nippon Kayaku.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
15 March 2017   Mylan has entered a settlement with Genentech and its parent company, Roche, in relation to patents for cancer drug Herceptin.

More on this story

Americas
15 March 2017   Mylan has entered a settlement with Genentech and its parent company, Roche, in relation to patents for cancer drug Herceptin.

More on this story

Americas
15 March 2017   Mylan has entered a settlement with Genentech and its parent company, Roche, in relation to patents for cancer drug Herceptin.